3[1]Chew DP, Moliterno DJ. Facilitated percutaneous coronary intervention for acute myocardial infarction: the role of adjunctive therapies. Acute coronary syndromes, 2000,3:.
4[2]Ross AM, Coyne KS, Reiner JS, et al. A randomized trial Comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue engioplasty in acute myocardial infarction: The PACT Trial. JACC, 1999,34:1954-1962.
5[3]Herrmann HC, Moliterno DJ, Ohman EM, et al. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4pilot) Trial. JACC, 2000,36:1489-1496.
6Simes RJ, Topoi EJ, Holmes DRJr, et al. Link between the angiographic sthstudy and mortalitry outcome in a large randomized trial of myocardial reperfusion. Impertance of early and complete infarct artery reperfusion GUSTO-I investigators [ J ]. Circulation, 1995,91 (7) : 1923 - 1928.
7Braunwald E, Antmem EM, Beasley JW, et al. ACC/AHA guidelines for the mamagement of patients with unstable, angina and non- ST-seg-ment elevation myoeardialinfaretion : a report of the Amriean College of Cardiology/american Heat Association Task Force onpractice Guide-Lines[J]. Jam Col Cardiol, 2000,36 ( 3 ) : 970 - 1062.
8Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review [J]. JAMA, 1997, 278(23): 2093-8.
9毛焕元 曹林生.心脏病学[M]:第2版[M].北京:人民卫生出版社,2000.1116-7.
10Zijlstra F, Hoomtje JC, de Boer MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction [J]. NEnglJMed, 1999, 341 (19):1413-9.
6Gibbons RJ,Ahrams J,Chatterjee K,et al.ACC / AHA 2002 guideline update for the management of patients with chronic stable.angina-summary article: a report of the American College of Cardiology / American Heart Association Task Force on Pactice Guidelines (Committee on the Management of patients with Chronic Stable Angina).Circulation,2003; 107:149-158.
7BI Y, GaoR.PateL A,et al.Evidence-based medication use among Chinese patients with acute coronary syndr rues at the time of discharge andl year offer hospitalization:results from the clinical pathways for acute coronary syndromes in China study.Am Heart J,2009; 157(3):509-16.
8Tawfik MK, Ghattas MH, Abo-Elmatty DM, et al. Atorv- astatin restores the balance between pro-inflammatory and anti-inflammatory mediators in rats with acute myocardial infarction[J]. Eur Rev Pharmacol Sci, 2010,14 (6)..499- 506.
9Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients[J]. Am J Cardiol, 1967,20(4) .. 457-464.
10Renilla A, Barreiro M, Diaz E, et al. Impact o~ reper{usion strategy on outcomes in very elderly patients with acute myocardialin{arction[J3. Minerva Cardioangiol, 2014, 62 (6) :473-479.
